Search research articles
Contact Us
Filters
Showing results (141-150 of 249) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study
Catherine Sebban, Pauline Brice, Richard Delarue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
Christian Gisselbrecht, Eric Lepage, Thierry Molina, et al.
Oncology (Williston Park, N.Y.)
|
April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directions
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
British Journal of Haematology
|
September 10, 2011
MicroRNA expression profile in splenic marginal zone lymphoma
Marie Bouteloup, Aurélie Verney, Nicolas Rachinel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2013
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial
Franck Morschhauser, Olivier Fitoussi, Corinne Haioun, et al.
Haematologica
|
June 2, 2017
Unmet needs in the scientific approach to older patients with lymphoma
Dominique Bron, Igor Aurer, Marc P E André, et al.
Blood
|
July 13, 2006
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Catherine Sebban, Nicolas Mounier, Nicole Brousse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome
Jean-François Larouche, Françoise Berger, Catherine Chassagne-Clément, et al.
Blood
|
August 16, 2003
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
Herve Tilly, Eric Lepage, Bertrand Coiffier, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 249) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study
Catherine Sebban, Pauline Brice, Richard Delarue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma
Christian Gisselbrecht, Eric Lepage, Thierry Molina, et al.
Oncology (Williston Park, N.Y.)
|
April 12, 2012
Splenic marginal zone lymphoma: current knowledge and future directions
Catherine Thieblemont, Frederic Davi, Maria-Elena Noguera, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
British Journal of Haematology
|
September 10, 2011
MicroRNA expression profile in splenic marginal zone lymphoma
Marie Bouteloup, Aurélie Verney, Nicolas Rachinel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2013
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial
Franck Morschhauser, Olivier Fitoussi, Corinne Haioun, et al.
Haematologica
|
June 2, 2017
Unmet needs in the scientific approach to older patients with lymphoma
Dominique Bron, Igor Aurer, Marc P E André, et al.
Blood
|
July 13, 2006
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Catherine Sebban, Nicolas Mounier, Nicole Brousse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome
Jean-François Larouche, Françoise Berger, Catherine Chassagne-Clément, et al.
Blood
|
August 16, 2003
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
Herve Tilly, Eric Lepage, Bertrand Coiffier, et al.
Page
of 25